NeuroPace重新关注产品组合;重申2025年收入指引

• NeuroPace (NASDAQ:NPCE) announced that it is refocusing its product portfolio on its core, differentiated RNS System product line.
• As part of this strategic shift, NPCE will terminate its distribution relationship for SEEG products, beginning in Q4, 2025 and continuing through Q1, 2026.
• NPCE is maintaining its 2025 revenue guidance.
• NeuroPace gross margin is expected to increase as the margin for SEEG distributed products is approximately 50%, while the margin of the RNS System is over 78%.
• Source: Press release

More on NeuroPace

• NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript
• NeuroPace, Inc. 2024 Q4 - Results - Earnings Call Presentation
• NeuroPace GAAP EPS of -$0.18 beats by $0.04, revenue of $21.47M beats by $0.33M
• NeuroPace stock dips after pricing $65M share offering
• Seeking Alpha’s Quant Rating on NeuroPace